Publication | Closed Access

Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 μg of ethinyl estradiol and 3 mg of drospirenone

ContraceptionContraceptive UseInfertilityHormonal ContraceptiveOral ContraceptiveMedicineCombined Contraceptive RingReproductive HealthGynecologyContraceptive UptakeEthinyl EstradiolHormonal Male ContraceptionPublic HealthPharmacologyReproductive Endocrinology